| 271 |
increased |
|
corticosterone
(CHEBI:16827)
|
653: Decreased testosterone by the fetal Leydig cells, Increased corticosterone
|
| 619 |
increased |
|
cough
(MESH:D003371)
|
2 Events
|
| 272 |
increased |
receptor transactivation
(GO:0035624)
|
COUP transcription factor 2
(PR:000011405)
|
655: Decreased testosterone by the fetal Leydig cells, Increased COUP-TFII in fetal Leydig cells
|
| 275 |
decreased |
receptor transactivation
(GO:0035624)
|
COUP transcription factor 2
(PR:000011405)
|
2 Events
|
| 440 |
increased |
|
creatinine
(CHEBI:16737)
|
813: Increased, Serum creatinine
|
| 749 |
decreased |
cuticle development
(GO:0042335)
|
cuticle
(UBERON:0001002)
|
1523: Decrease, Cuticular chitin content
|
| 156 |
occurrence |
|
Cyanosis
(MESH:D003490)
|
321: N/A, Cyanosis occurs
|
| 700 |
increased |
positive regulation of gene expression
(GO:0010628)
|
cyclin-dependent kinase inhibitor
(PR:000000014)
|
1504: p21 (CDKN1A) expression, increase
|
| 493 |
increased |
protein glutathionylation
(GO:0010731)
|
cysteine residue
(CHEBI:32460)
|
927: KE1 : S-Glutathionylation, eNOS
|
| 243 |
increased |
gene expression
(GO:0010467)
|
cytochrome P450 1A1
(PR:000006101)
|
80: Up Regulation, CYP1A1
|
| 453 |
increased |
gene expression
(GO:0010467)
|
cytochrome P450 1A2
(PR:000006102)
|
850: Induction, CYP1A2/CYP1A5
|
| 454 |
increased |
gene expression
(GO:0010467)
|
cytochrome P450 1A5 (chicken)
(PR:P79761)
|
850: Induction, CYP1A2/CYP1A5
|
| 691 |
increased |
acute inflammatory response
(GO:0002526)
|
Cytokine
(FMA:84050)
|
None
|
| 127 |
increased |
cytokine secretion
(GO:0050663)
|
Cytokine
(FMA:84050)
|
87: Release, Cytokine
|
| 196 |
increased |
cytokine activity
(GO:0005125)
|
Cytokine
(FMA:84050)
|
151: Activation, Inflammatory cytokines, chemokines, cytoprotective gene pathways
|
| 852 |
increased |
|
Cytokine
(FMA:84050)
|
None
|
| 853 |
increased |
cytokine production involved in inflammatory response
(GO:0002534)
|
Cytokine
(FMA:84050)
|
1496: Increased, secretion of proinflammatory mediators
|
| 318 |
decreased |
glucose oxidase activity
(GO:0046562)
|
D-glucono-1,5-lactone
(CHEBI:16217)
|
578: Decreased, Glucose oxidase enzyme activity
|
| 78 |
increased |
|
decreased heart rate
(MESH:D001919)
|
444: Increased, Atrioventricular block and bradycardia
|
| 60 |
abnormal |
dendrite morphogenesis
(GO:0048813)
|
dendrite
(GO:0030425)
|
382: Aberrant, Dendritic morphology
|
| 981 |
morphological change |
abnormal excitatory postsynaptic current amplitude
(MP:0011267)
|
dendritic spine membrane
(GO:0032591)
|
388: Overactivation, NMDARs
|
| 994 |
increased |
DNA Strand Break
(NCI:C25830)
|
Deoxyribonucleic acid
(FMA:74412)
|
1635: Increase, DNA strand breaks
|
| 1000 |
abnormal |
DNA repair
(GO:0006281)
|
deoxyribonucleic acid
(CHEBI:16991)
|
155: Inadequate DNA repair
|
| 774 |
increased |
|
deoxyribonucleic acid
(CHEBI:16991)
|
1879: Bulky DNA adducts, increase
|
| 634 |
increased |
oxidation-reduction process
(GO:0055114)
|
deoxyribonucleic acid
(CHEBI:16991)
|
1238: Activation of oxidative stress pathway
|